Abstract
Oxidative stress disrupts nutrient metabolism and may impair muscle development in piglets. This study investigated whether dietary ellagic acid (EA) supplementation alleviates paraquat (PQ)-induced oxidative stress and metabolic disturbances in the longissimus dorsi muscle of piglets. Piglets were assigned to a control group, a PQ-challenged group, and a PQ-challenged group supplemented with 0.01% EA. PQ challenge did not significantly affect final body weight or average daily gain but impaired antioxidant status, as evidenced by decreased serum total antioxidant capacity and glutathione peroxidase activity and reduced superoxide dismutase and glutathione levels in the longissimus dorsi muscle. EA supplementation significantly increased these four antioxidant indices relative to PQ alone. PQ also decreased the expression of several muscle development-related genes, including MYOD, MYOG, DESMIN, and CAV3, whereas EA significantly increased CAV3, FOXO1, P21, and MCP-1 expression relative to PQ alone without significantly altering MYOD, MYOG, or DESMIN. Furthermore, PQ markedly altered the amino acid profile of the longissimus dorsi muscle and reduced the expression of amino acid transporters, including SLC1A1 and SLC6A6. EA supplementation increased muscle Tau, Glu, Ile, Leu, Phe, and Pro concentrations, increased SLC1A1 and SLC6A6 expression, and decreased PRODH, OAT, and ODC expression relative to PQ alone. PQ challenge also disrupted the long-chain fatty acid profile and suppressed genes involved in fatty acid handling, whereas EA increased FABP3, CD36, and PLIN3 expression and increased C18:3N-3 and C22:1N-9 relative to PQ alone. Overall, these findings suggest that EA may alleviate selected PQ-associated biochemical and metabolic disturbances by improving antioxidant status and modulating muscle amino acid and lipid metabolism.
Keywords: amino acid metabolism, ellagic acid, fatty acid metabolism, muscle, oxidative stress, paraquat, piglets
1. Introduction
Oxidative stress (OS) is an important physiological challenge affecting the health, growth, and metabolic homeostasis of weaned piglets. Excessive production of reactive oxygen species (ROS) can disrupt redox homeostasis, impair nutrient utilization, and cause cellular and tissue damage (1–3). Paraquat (PQ), a potent redox-cycling compound, has therefore been widely used to establish experimental models of OS (4). Previous studies have demonstrated that PQ exposure induces oxidative injury in piglets, particularly in the intestine and liver, and is accompanied by impaired antioxidant capacity and enhanced inflammatory responses (5–7). However, the effects of PQ-induced OS on skeletal muscle homeostasis and nutrient metabolism in piglets remain less well characterized.
Ellagic acid (EA) is a naturally occurring polyphenol with well-established antioxidant and anti-inflammatory properties (8, 9). Dietary EA supplementation has been reported to alleviate PQ-induced intestinal and hepatic injury in piglets by enhancing antioxidant defenses and modulating antioxidant-related signaling pathways (5, 10, 11). In addition, EA supplementation has been shown to improve antioxidant capacity and intestinal health in weaned piglets (12–15). These findings suggest that EA may exert protective effects against oxidative damage in multiple tissues. However, whether EA can alleviate PQ-induced oxidative injury and metabolic disturbances in skeletal muscle remains unclear.
The longissimus dorsi muscle is an important tissue for postnatal growth, protein deposition, and nutrient metabolism in pigs. Normal muscle development and function depend on the coordinated regulation of cellular homeostasis, nutrient availability, and metabolic processes (16–18). Amino acids are essential substrates for muscle protein synthesis and also participate in energy metabolism and other cellular functions. The composition, transport, and utilization of amino acids in skeletal muscle are therefore closely associated with muscle growth and metabolic homeostasis (19–25). Oxidative stress may disturb amino acid availability and metabolism, thereby affecting muscle development and function.
Lipid metabolism is also essential for maintaining energy supply and cellular integrity in skeletal muscle. Long-chain fatty acids serve as important energy substrates and structural components of cellular membranes, while their uptake, transport, storage, and oxidation are tightly regulated to maintain lipid homeostasis (26–29). Disruption of these processes under oxidative stress may contribute to metabolic imbalance and impair muscle function. Therefore, characterization of alterations in amino acid and lipid metabolism may provide important insights into the metabolic consequences of oxidative stress in skeletal muscle.
However, the role of EA in protecting skeletal muscle against PQ-induced oxidative and metabolic disturbances remains unclear. Therefore, this study investigated the effects of dietary EA supplementation on growth performance, antioxidant status, muscle development, and amino acid and fatty acid metabolism in the longissimus dorsi muscle of PQ-challenged piglets. We hypothesized that EA would alleviate PQ-induced oxidative stress and metabolic disturbances in piglet muscle.
2. Materials and methods
2.1. Animals and experimental design
A total of 18 healthy castrated male piglets (Duroc × Landrace × Large Yorkshire), weaned at 21 days of age, were randomly assigned to three treatment groups (n = 6 per group) using Microsoft Excel, with similar initial body weights across groups. The treatments were as follows: the control group (Control), fed a basal diet and intraperitoneally injected with 0.9% sterile saline; the PQ group, fed a basal diet and intraperitoneally injected with paraquat; and the EA group, fed the basal diet supplemented with 100 mg EA/kg diet and intraperitoneally injected with paraquat. The EA supplementation level was selected based on previous research findings (5). EA, with a purity of 98%, was provided by Sai’en Inc. (Xi’an, China). The experimental design is illustrated in Figure 1. Paraquat solution was prepared by dissolving paraquat powder (Sigma–Aldrich, Inc., St. Louis, MO, USA) in 0.9% sterile saline to a final concentration of 4 mg/mL. On day 18 of the experiment, piglets in the PQ and EA groups received a single intraperitoneal injection of paraquat at a dose of 4 mg paraquat ion/kg body weight, whereas piglets in the Control group received an equivalent volume of 0.9% sterile saline. The entire experimental period lasted 21 days. All piglets were individually housed in an environmentally controlled nursery with hard plastic slatted flooring and had ad libitum access to feed and water throughout the experiment. The basal diet was formulated to meet or exceed the nutrient requirements of weaned piglets recommended by the National Research Council (NRC, 2012) (Table 1). At the end of the 21-day experimental period, all piglets were humanely euthanized by intravenous administration of sodium pentobarbital at a dose of 100 mg/kg body weight, in accordance with the approved animal welfare and ethical guidelines. After confirmation of death, the animals were exsanguinated, and blood and tissue samples were collected immediately for subsequent analyses.
Figure 1.

Animal experimental design.
Table 1.
Ingredient composition of diets.
| Items | Percent (%) |
|---|---|
| Corn | 32.20 |
| Extruded corn | 30.00 |
| Soybean meal | 10.14 |
| Fermented soybean | 8.00 |
| Whey powder | 5.00 |
| Fish meal | 5.00 |
| Soybean oil | 2.00 |
| Glucose | 3.00 |
| L-lysine | 0.55 |
| DL-methionine | 0.07 |
| L-threonine | 0.20 |
| L-tryptophan | 0.04 |
| Limestone | 0.20 |
| Calcium hydrophosphate | 0.40 |
| Calcium formate | 0.60 |
| Sodium chloride | 0.40 |
| Citric acid | 0.80 |
| Choline chloride | 0.10 |
| ZnO | 0.20 |
| Antioxidant | 0.10 |
| Premixa | 1.00 |
| Total | 100 |
| Nutritional value | |
| Dry matterb | 89.58 |
| Crude protienb | 16.20 |
| Ether extractb | 17.58 |
| DE, MJ/kg | 15.41 |
The premix provided the following per kg of diets: Zn (ZnO) 50.00 mg, Cu (CuSO4) 20.00 mg, Mn (MnO) 55.00 mg, Fe (FeSO4) 100.00 mg, I (KI) 1.00 mg, Co (CoSO4) 2.00 mg, Se (Na2SeO3) 0.30 mg, VA 8255.00 IU, VD3 2000.00 IU, VE 40.00 IU, VB1 2.00 mg, VB2 4.00 mg, VC 100.00 mg, VK3 1.50 mg, VB6 10.00 mg, VB12 0.05 mg, nicotinic acid 30.00 mg, folic acid 2.00 mg, biotin 0.20 mg, pantothenic acid 15.00 mg.
Is measured value.
2.2. Sample collection
At the end of the experimental period, piglets were euthanized for serum and longissimus dorsi muscle sample collection. After overnight fasting, approximately 10 mL of blood was aseptically collected from the jugular vein and centrifuged at 3,000 × g for 10 min at 4 °C to obtain serum. The serum samples were stored at −80 °C until further analysis. Longissimus dorsi muscle samples were rapidly collected, immediately snap-frozen in liquid nitrogen, and stored at −80 °C for subsequent biochemical, gene expression, and fatty acid analyses.
2.3. Growth performance
Piglets were individually weighed at the start of the experiment and on days 18 and 21. Average daily gain (ADG) was calculated as body weight gain divided by the number of days in each interval.
2.4. Blood parameters analysis
Serum biochemical parameters were determined spectrophotometrically using an automated biochemical analyzer (BS-200; Mindray, Shenzhen, China). The measured parameters included total protein (TP), albumin (ALB), globulin (GLB), alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), creatinine (CREA), glucose (GLU), triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C).
2.5. Determination of antioxidant parameters
Antioxidant parameters in serum and longissimus dorsi muscle were determined using commercial porcine enzyme-linked immunosorbent assay (ELISA) kits (Jiangsu Meimian Industrial Co., Ltd., Yancheng, Jiangsu, China) according to the manufacturer’s instructions. The parameters assessed included total antioxidant capacity (T-AOC; MM-77610O2) and glutathione peroxidase (GPx; MM-1927O2) in serum, as well as superoxide dismutase (SOD; MM-0450O2) and glutathione (GSH; MM-1915O2) in longissimus dorsi muscle.
2.6. Determination of amino acid contents
The free amino acid concentrations in serum and longissimus dorsi muscle were determined using an automatic amino acid analyzer (L-8900, Hitachi, Tokyo, Japan). Sample preparation was performed as follows. Briefly, longissimus dorsi muscle samples were homogenized with 5 mL of 0.01 M hydrochloric acid and subjected to ultrasonic extraction for 30 min. After centrifugation, 1 mL of the supernatant was mixed with 0.8% sulfosalicylic acid solution for protein precipitation. The mixture was incubated at 4 °C for 15 min and subsequently centrifuged at 10,000 rpm for 20 min. The resulting supernatant was filtered through a 0.22-μm membrane filter prior to HPLC analysis. Serum samples were processed using the same procedure, except that the initial homogenization and ultrasonic extraction steps were omitted.
2.7. Real-time quantitative PCR (RT-qPCR)
Total RNA was extracted from longissimus dorsi muscle samples using TRIzol reagent (Cat. No. 15596026; Thermo Fisher Scientific, USA) according to the manufacturer’s instructions. RNA concentration and purity were assessed using a NanoDrop One microvolume UV–Vis spectrophotometer (Thermo Fisher Scientific, USA). The A260/A280 ratios ranged from 1.8 to 2.1. Genomic DNA removal and complementary DNA (cDNA) synthesis were performed using an Evo M-MLV RT Kit with gDNA Clean for qPCR (Cat. No. AG11705; Accurate Biotechnology (Hunan) Co., Ltd., Changsha, China). Briefly, 1 μg of total RNA was subjected to the genomic DNA removal step included in the kit and subsequently reverse-transcribed in a total reaction volume of 10 μL using a combination of oligo(dT)₁₈ primers and random hexamers, according to the manufacturer’s instructions. The resulting cDNA was diluted 10-fold with nuclease-free water and used as the template for quantitative real-time PCR (qRT-PCR). qRT-PCR was performed using a SYBR Green Premix Pro Taq HS qPCR Kit (Accurate Biotechnology (Hunan) Co., Ltd., Changsha, China) on a LightCycler 480 II Real-Time PCR System (Roche). Each 10 μL reaction contained 5 μL of 2 × SYBR Green master mix, 0.4 μL each of the forward and reverse primers, 4 μL of 10-fold diluted cDNA, and 0.2 μL of nuclease-free water. The amplification conditions consisted of initial denaturation at 95 °C for 30 s, followed by 35 cycles of denaturation at 95 °C for 5 s, annealing at 60 °C for 15 s, and extension at 72 °C for 10 s. Melting-curve analysis was subsequently performed to assess amplification specificity. Each group included six biological replicates, and each sample was analyzed in three technical replicates for each gene. The mean Ct value of the technical replicates was used for subsequent analysis. Relative expression levels of target genes were calculated using the 2−ΔΔCt method and normalized to β-actin expression (5, 30). The primer sequences used for qRT-PCR are listed in Table 2.
Table 2.
Primer sequences.
| Gene | Forward primer 5′–3′ | Reverse primer 5′–3′ |
|---|---|---|
| β-Actin | CTGCGGCATCCACGAAACT | AGGGCCGTGATCTCCTTCTG |
| MYOD | AACCCCACTTCTATGACGGG | TTATCTTCCAGGGGCACTCG |
| DESMIN | GCTGGGGGCCCTGTC | GTAAGAGGACACGCGCTGG |
| FOXO1 | GCAAATCGAGTTACGGAGGC | AATGTCATTATGGGGAGGAGAGT |
| SLC1A1 | GGCGCGGTGAGCAATCT | GAGCGCAGTGAAGGAAGGTT |
| SLC1A2 | GGTTCTAAGGGACTGGCTTGC | ACGGGGAGAGAAAGACTCACT |
| SLC6A6 | ATGGGTGATGCTGAGAGCTG | CCAGCGAGCGGAGCAG |
| SLC36A1 | AGCCCAGGGAAATCTCCTCA | GCGCGTCATACACTTGCTTC |
| PRODH | AAACTTGCTACCTCCAGAGCC | CACCATCAAAGTTCGGGGGC |
| OAT | AAGAAAGGATAGTTGGGTTGCTG | GTCGCAGAAGCCACTGTAGAA |
| ODC | AGTAACGAGGAGTTGGACTGC | TTTGAGCCATCTCAGGTGCTT |
| SLC25A2 | AGGCTGGCAAAAAGCCCTAA | ATCTTTTGATCCCCCGGACG |
| MYOG | CTGGTGGCAGGAACAAGTCT | GCAGGTAGTTTTCCCCGTCA |
| P21 | GAGGTTTGCCTGGGGACTG | TGGAAGGAATGTGGCTGTGG |
| CAV3 | CCCAGATCGTCAAGGACATTC | GTGTAGCTCACCTTCCACACG |
| MCP-1 | CATCCTCCAGCATGAAGGTCT | ATTAATTGCATCTGGCTGGGC |
| FABP1 | TTCATGAAGGCAGTCGGTCT | CACGATTTCCGATGTCCCCT |
| FABP3 | TGGAAGCTAGTGGACAGCAAG | TTGTGGTAGGCTTGGTCATGT |
| FABP4 | TCCTGAAGGTTACGGCTTCT | AAGCCCACTCCCACTTCTTT |
| FATP4 | AGCCTGCTCCTTCCAAACTG | CCACTAGAGATGCCCCAAGC |
| CD36 | CACTGCCTCACTGGAGTGTT | TGCTTCAAGTGCTGGGTCAA |
| CAV1 | CGTAGACTCGGAGGTAGGCA | GGGCAGCAGTCGGGATATTT |
| DGAT1 | CGGCAGGAGGCGGTG | CCTCTGCCTGCACCCTG |
| PLIN2 | TGCTGCTGGTCGATTTCTTACT | GTGGAGCTCACCAAGGGTAG |
| PLIN3 | CTTGAAGTAGCTGCTGTTGCAC | CCATAGCTCCCAGACCTTCCT |
| PNPLA2 | CCCAAAGAGACGACGTGGAA | CGTAGATGTGCTTGGCGTTG |
| CPT1B | GCTGTGGCCTTCCAATTCAC | AGGATGCCATTCTTGATGCGA |
| PPARα | CCAACATGGTGGACACGGAA | GCTTCCAGAACTGTCCTCACC |
2.8. Determination of medium and long chain fatty acids
Medium- and long-chain fatty acids in the longissimus dorsi muscle were analyzed by gas chromatography coupled with flame ionization detection (GC-FID) using an Agilent 6890N gas chromatograph (Agilent Technologies, Chicago, IL, USA) equipped with a DB-23 capillary column (60 m × 0.25 mm × 0.25 μm). Briefly, LD muscle samples were freeze-dried and ground into a fine powder. Approximately 0.1 g of each sample was accurately weighed into a 50-mL centrifuge tube. Subsequently, 4 mL of a benzene–petroleum ether mixed solvent was added, and the tubes were sealed and extracted for 24 h. After extraction, 4 mL of potassium hydroxide–methanol solution was added, and the mixture was vortexed for 3 min and allowed to stand for 30 min. Ultrapure water was then added to facilitate phase separation. The upper organic phase was collected, and an appropriate amount of anhydrous sodium sulfate was added to remove residual moisture. Finally, 200 μL of the resulting solution was diluted with 800 μL of hexane and filtered through a 0.22-μm membrane filter prior to GC-FID analysis. A 37-component fatty acid methyl ester (FAME) standard mixture (Sigma-Aldrich; 47,885-U) was used as the reference standard for GC-FID analysis.
2.9. Statistical analysis
All statistical analyses were performed using IBM SPSS Statistics 20.0 (IBM Corp., Armonk, NY, USA). Differences between two groups were analyzed using an independent-samples t-test. Specifically, comparisons were performed between the Control and PQ groups and between the PQ and EA groups. Results are presented as the mean ± standard error of the mean (SEM). Differences were considered statistically significant at p < 0.05. In the tables, pt-valuea represents the comparison between the Control and PQ groups, whereas pt-valueb represents the comparison between the EA and PQ groups.
3. Results
3.1. Effects of EA supplementation on growth performance in PQ-challenged piglets
As shown in Table 3, Figure 2, during the pre-challenge period (days 1–18), initial body weight (BW), BW on day 18, and average daily gain (ADG) did not differ among the control, PQ, and EA groups (p > 0.05). Likewise, during the PQ-challenge period (days 18–21), no between-group differences were observed in BW on day 18, final BW, or ADG (p > 0.05). Paired-samples t-tests showed that BW significantly increased from day 18 to day 21 in the control and EA groups (p < 0.05), whereas no significant change was observed in the PQ group (p > 0.05).
Table 3.
Growth performance of piglets.
| Period | Item | Control group | PQ group | EA group | Pt-valuea | Pt-valueb |
|---|---|---|---|---|---|---|
| 1–18d | Initial BW (kg) | 8.81 ± 0.45 | 8.79 ± 0.49 | 8.81 ± 0.44 | 0.88 | 0.97 |
| 18d BW (kg) | 15.34 ± 1.10 | 16.80 ± 1.02 | 16.15 ± 0.92 | 0.17 | 0.92 | |
| ADG (g/d) | 477.38 ± 88.90 | 575.00 ± 52.96 | 544.05 ± 46.89 | 0.37 | 0.67 | |
| 18–21d | 18d BW (kg) | 15.36 ± 1.10 | 16.84 ± 1.02 | 16.15 ± 0.92 | 0.51 | 0.63 |
| Final BW (kg) | 16.53 ± 1.14 | 17.42 ± 1.29 | 16.91 ± 1.07 | 0.56 | 0.73 | |
| ADG (g/d) | 397.22 ± 27.69 | 300.00 ± 85.80 | 336.67 ± 39.23 | 0.27 | 0.70 |
Data are presented as mean ± SEM, n = 6 for each group.
Pt: Control vs PQ.
Pt: EA vs PQ.
Figure 2.

Changes in body weight from day 18 to day 21 in the control, PQ, and EA groups. Body weights on days 18 (d18) and 21 (d21) within each group were compared using a paired-samples t-test. n = 6 for each group. *Indicates significant difference (p < 0.05).
3.2. Effects of EA supplementation on serum biochemical parameters in PQ-challenged piglets
As shown in Table 4, compared with the control group, PQ challenge significantly decreased serum ALB concentration (p < 0.01) and tended to decrease LDL concentration (p = 0.07). EA supplementation did not significantly alter any of the measured serum biochemical parameters relative to the PQ group (p > 0.05).
Table 4.
Effects of EA supplementation on serum biochemical parameters in PQ-challenged piglets.
| Item | Control group | PQ group | EA group | Pt-valuea | Pt-valueb |
|---|---|---|---|---|---|
| TP (g/L) | 66.79 ± 2.75 | 64.68 ± 2.66 | 67.73 ± 2.28 | 0.60 | 0.95 |
| ALB (g/L) | 43.01 ± 0.93 | 37.22 ± 1.04 | 42.03 ± 1.50 | < 0.01 | 0.27 |
| GLB (g/L) | 23.77 ± 2.63 | 27.47 ± 2.23 | 25.70 ± 2.14 | 0.24 | 0.93 |
| ALT (U/L) | 67.60 ± 10.26 | 68.47 ± 8.87 | 76.11 ± 8.48 | 0.95 | 0.39 |
| AST(U/L) | 168.57 ± 19.50 | 176.50 ± 21.56 | 199.00 ± 32.19 | 0.79 | 0.86 |
| ALP (U/L) | 206.86 ± 22.91 | 206.50 ± 21.21 | 195.71 ± 33.38 | 0.99 | 0.64 |
| CREA (μmol/L) | 91.86 ± 8.92 | 97.83 ± 3.34 | 97.43 ± 6.39 | 0.55 | 0.51 |
| GLU (mmol/L) | 8.31 ± 1.11 | 7.58 ± 0.31 | 7.91 ± 0.32 | 0.57 | 0.28 |
| TG (mmol/L) | 0.68 ± 0.05 | 0.68 ± 0.08 | 0.61 ± 0.06 | 0.96 | 0.18 |
| CHO (mmol/L) | 3.36 ± 0.30 | 2.73 ± 0.18 | 2.77 ± 0.17 | 0.11 | 0.78 |
| HDL (mmol/L) | 1.22 ± 0.14 | 1.12 ± 0.06 | 1.13 ± 0.10 | 0.52 | 0.59 |
| LDL (mmol/L) | 2.05 ± 0.20 | 1.57 ± 0.13 | 1.66 ± 0.12 | 0.07 | 0.88 |
Data are presented as mean ± SEM, n = 6 for each group.
Pt: Control vs. PQ.
Pt: EA vs PQ.
3.3. Effects of EA supplementation on antioxidant status in serum and longissimus dorsi muscle of PQ-challenged piglets
As shown in Figure. 3, PQ challenge significantly decreased T-AOC and GPx, as well as longissimus dorsi muscle SOD and GSH, compared with the control group (p < 0.05). EA supplementation significantly increased all four antioxidant-related indices relative to the PQ group (p < 0.05), indicating a partial restoration of antioxidant status in both serum and longissimus dorsi muscle.
Figure 3.

Effects of EA supplementation on antioxidant parameters in serum and longissimus dorsi muscle of PQ-challenged piglets. (A) Serum of T-AOC and GPx activity. (B) SOD activity and GSH content in the longissimus dorsi muscle. Data are presented as mean ± SEM. n = 6 for each group. *Indicates significant difference (p < 0.05).
3.4. Effects of EA supplementation on longissimus dorsi muscle development and injury related gene expression in PQ-challenged piglets
As shown in Figure. 4, compared with the control group, PQ challenge significantly decreased the longissimus dorsi muscle mRNA abundance of MYOD, MYOG, DESMIN, and CAV3 (p < 0.05), whereas FOXO1, P21, and MCP-1 were not significantly altered (p > 0.05). Relative to the PQ group, EA supplementation significantly increased FOXO1, P21, CAV3, and MCP-1 mRNA abundance (p < 0.05), while MYOD, MYOG, and DESMIN remained unchanged (p > 0.05).
Figure 4.

Effects of EA supplementation on muscle development and injury-related gene expression in the longissimus dorsi muscle of PQ-challenged piglets. Relative mRNA expression levels of MYOD, MYOG, FOXO1, DESMIN, P21, CAV3, and MCP-1 were determined by RT-qPCR. Data are presented as mean ± SEM. n = 6 for each group. *Indicates significant difference (p < 0.05).
3.5. Effects of EA supplementation on serum and longissimus dorsi muscle amino acid profiles in PQ-challenged piglets
As shown in Table 5, PQ challenge altered the serum amino acid profile. Compared with the control group, serum Asp., Ser, Gly, Ile, and Phe concentrations were significantly decreased (p < 0.05), while Ala and Pro showed decreasing trends (0.05 ≤ p < 0.10). Relative to the PQ group, EA supplementation significantly increased serum Asp concentration (p < 0.05), and Cys showed an increasing trend (p = 0.06); no other serum amino acids were significantly affected.
Table 5.
Effects of EA supplementation on serum amino acid contents in PQ-challenged piglets (μg/mL).
| Item | Control group | PQ group | EA group | Pt-valuea | Pt-valueb |
|---|---|---|---|---|---|
| Tau | 3.39 ± 0.79 | 2.13 ± 0.26 | 2.60 ± 0.14 | 0.18 | 0.16 |
| Asp | 0.62 ± 0.13 | 0.23 ± 0.22 | 0.48 ± 0.05 | 0.03 | 0.02 |
| Thr | 4.50 ± 0.74 | 3.51 ± 0.54 | 3.05 ± 0.20 | 0.31 | 0.47 |
| Ser | 6.43 ± 0.46 | 4.72 ± 0.24 | 5.09 ± 0.31 | 0.01 | 0.36 |
| Glu | 17.60 ± 1.62 | 15.28 ± 2.59 | 14.20 ± 1.40 | 0.47 | 0.66 |
| Gly | 26.53 ± 1.60 | 18.95 ± 2.31 | 19.68 ± 1.64 | <0.01 | 0.57 |
| Ala | 24.65 ± 3.38 | 17.35 ± 1.60 | 19.69 ± 2.19 | 0.09 | 0.41 |
| Cit | 4.37 ± 0.27 | 3.74 ± 0.53 | 3.51 ± 0.36 | 0.31 | 0.73 |
| Val | 9.90 ± 0.81 | 7.91 ± 0.73 | 7.65 ± 0.39 | 0.10 | 0.76 |
| Cys | 0.78 ± 0.28 | 0.31 ± 0.08 | 0.57 ± 0.70 | 0.14 | 0.06 |
| Met | 1.66 ± 0.19 | 1.38 ± 0.19 | 1.24 ± 0.86 | 0.33 | 0.51 |
| Ile | 5.74 ± 0.56 | 3.54 ± 0.76 | 3.51 ± 0.31 | 0.02 | 0.97 |
| Leu | 8.50 ± 0.70 | 6.92 ± 0.67 | 6.31 ± 0.29 | 0.14 | 0.44 |
| Tyr | 3.69 ± 0.34 | 2.76 ± 0.47 | 2.44 ± 0.18 | 0.14 | 0.53 |
| Phe | 5.00 ± 0.47 | 3.56 ± 0.35 | 4.03 ± 0.24 | 0.03 | 0.15 |
| Orn | 4.74 ± 0.41 | 4.45 ± 0.60 | 4.45 ± 0.83 | 0.70 | 0.99 |
| Lys | 11.94 ± 1.07 | 10.16 ± 1.64 | 7.93 ± 0.68 | 0.38 | 0.25 |
| His | 3.35 ± 0.25 | 2.85 ± 0.46 | 2.88 ± 0.33 | 0.36 | 0.23 |
| Arg | 9.01 ± 1.55 | 5.52 ± 1.66 | 5.53 ± 1.12 | 0.16 | 0.89 |
| Pro | 7.91 ± 0.54 | 6.14 ± 0.67 | 6.54 ± 0.72 | 0.07 | 0.70 |
Data are presented as mean ± SEM, n = 6 for each group.
Pt: Control vs. PQ.
Pt: EA vs. PQ.
As shown in Table 6, In longissimus dorsi muscle, PQ challenge significantly decreased Tau, Glu, Cys, and Pro concentrations and increased Thr, Orn, and Lys concentrations compared with the control group (p < 0.05), with Gly showing a decreasing trend (p = 0.08). Compared with the PQ group, EA supplementation significantly increased Tau, Glu, Ile, Leu, Phe, and Pro concentrations and decreased Thr, Orn, and Lys concentrations (p < 0.05). Collectively, EA exerted a broader effect on the muscle amino acid profile than on the serum amino acid profile.
Table 6.
Effects of EA supplementation on longissimus dorsi muscle amino acid contents in PQ-challenged piglets (μg/mL).
| Item | Control group | PQ group | EA group | Pt-valuea | Pt-valueb |
|---|---|---|---|---|---|
| Tau | 643.44 ± 10.93 | 461.26 ± 55.12 | 885.30 ± 144.57 | 0.02 | 0.04 |
| Asp | 18.17 ± 1.27 | 29.00 ± 10.43 | 34.13 ± 5.22 | 0.35 | 0.67 |
| Thr | 67.89 ± 1.41 | 93.33 ± 6.60 | 57.94 ± 6.21 | 0.01 | <0.01 |
| Ser | 117.03 ± 2.31 | 98.42 ± 10.81 | 99.48 ± 9.08 | 0.15 | 0.94 |
| Glu | 246.81 ± 3.33 | 31.50 ± 5.63 | 260.95 ± 34.28 | <0.01 | <0.01 |
| Gly | 694.16 ± 11.35 | 572.19 ± 67.01 | 591.80 ± 83.04 | 0.08 | 0.86 |
| Ala | 672.90 ± 10.34 | 608.40 ± 61.83 | 661.70 ± 112.74 | 0.35 | 0.69 |
| Cit | 58.77 ± 1.12 | 48.14 ± 6.72 | 49.74 ± 8.15 | 0.18 | 0.88 |
| Val | 47.85 ± 0.79 | 50.20 ± 4.58 | 50.69 ± 5.49 | 0.63 | 0.95 |
| Cys | 31.68 ± 1.28 | 12.60 ± 5.92 | 19.37 ± 6.26 | 0.02 | 0.45 |
| Met | 27.35 ± 1.26 | 30.53 ± 1.58 | 35.95 ± 5.44 | 0.14 | 0.33 |
| Ile | 54.21 ± 2.08 | 49.00 ± 4.69 | 64.17 ± 8.98 | 0.31 | 0.02 |
| Leu | 88.36 ± 1.88 | 84.24 ± 6.52 | 108.18 ± 10.29 | 0.57 | 0.03 |
| Tyr | 25.30 ± 3.86 | 31.37 ± 6.80 | 35.73 ± 7.30 | 0.44 | 0.66 |
| Phe | 56.84 ± 3.50 | 48.29 ± 4.13 | 65.64 ± 5.93 | 0.14 | 0.04 |
| Orn | 5.42 ± 2.47 | 28.59 ± 6.32 | 13.77 ± 2.42 | 0.01 | 0.04 |
| Lys | 109.38 ± 2.79 | 195.39 ± 17.94 | 110.06 ± 27.07 | <0.01 | 0.02 |
| His | 5.42 ± 3.27 | 10.57 ± 3.62 | 12.28 ± 7.12 | 0.31 | 0.83 |
| Arg | 7.15 ± 4.13 | 5.14 ± 1.70 | 8.43 ± 2.46 | 0.67 | 0.29 |
| Pro | 150.53 ± 11.28 | 10.93 ± 4.69 | 84.25 ± 18.39 | <0.01 | <0.01 |
Data are presented as mean ± SEM, n = 6 for each group.
Pt: Control vs. PQ.
Pt: EA vs. PQ.
3.6. Effects of EA supplementation on amino acid transport- and metabolism-related gene expression in longissimus dorsi muscle
As shown in Figure.5, compared with the control group, PQ challenge significantly decreased the mRNA abundance of SLC1A1, SLC6A6, SLC25A2, and SLC36A1 and increased ODC expression in longissimus dorsi muscle (p < 0.05). PRODH expression also showed an increasing trend following PQ challenge (p = 0.052). Relative to the PQ group, EA supplementation significantly increased SLC1A1 and SLC6A6 expression and decreased PRODH, OAT, and ODC expression (p < 0.05). EA supplementation also tended to decrease SLC1A2 expression (p = 0.096), whereas SLC25A2 and SLC36A1 were not significantly altered (p > 0.05).
Figure 5.

Effects of EA supplementation on amino acid transport and metabolism related gene expression in the longissimus dorsi muscle of PQ-challenged piglets. Relative mRNA expression levels of SLC1A1, SLC1A2, SLC6A6, SLC25A2, SLC36A1, PRODH, OAT, and ODC were determined by RT-qPCR. Data are presented as mean ± SEM. n = 6 for each group. *Indicates significant difference (p < 0.05).
3.7. Effects of EA supplementation on the longissimus dorsi muscle long-chain fatty acid profile in PQ-challenged piglets
As shown in Table 7, compared with the control group, PQ challenge significantly increased longissimus dorsi muscle C18:3N-6, C20:1, C20:3N-6, and C24:0 concentrations, while decreasing C18:3N-3 and C22:1N-9 concentrations (p < 0.05). PQ challenge also tended to decrease C16:1, C18:1N-9T, and C20:2 and to increase C20:4N-6 and C22:6N-3 (0.05 ≤ p < 0.10). Relative to the PQ group, EA supplementation significantly increased C18:3N-3 and C22:1N-9 concentrations (p < 0.05), tended to increase C16:1, and tended to decrease C18:0 and C20:3N-6 (0.05 ≤ p < 0.10). Thus, EA supplementation partially normalized selected PQ-associated changes in the longissimus dorsi muscle fatty acid profile.
Table 7.
Effects of EA supplementation on the longissimus dorsi muscle long-chain fatty acid profile in PQ-challenged piglets.
| Item | Control group | PQ group | EA group | Pt-valuea | Pt-valueb |
|---|---|---|---|---|---|
| C14:0 | 12.09 ± 0.29 | 13.67± 0.99 | 12.03 ± 0.66 | 0.158 | 0.186 |
| C16:0 | 241.48 ± 5.49 | 226.10 ± 14.26 | 208.85 ± 5.68 | 0.465 | 0.259 |
| C16:1 | 28.37± 0.99 | 22.64 ± 2.45 | 28.16 ± 1.54 | 0.055 | 0.075 |
| C17:0 | 2.22 ± 0.06 | 2.19 ± 0.35 | 2.00 ± 1.48 | 0.806 | 0.397 |
| C18:0 | 112.70 ± 2.83 | 138.99 ± 14.38 | 113.61± 2.56 | 0.103 | 0.087 |
| C18:1N9T | 1.12 ± 0.05 | 0.97 ± 0.06 | 0.99± 0.05 | 0.099 | 0.739 |
| C18:1N9C | 260.11 ± 7.95 | 279.83 ± 24.96 | 269.85 ±8.67 | 0.469 | 0.695 |
| C18:2N6C | 259.71 ± 7.75 | 219.48 ± 24.25 | 250.33±9.36 | 0.145 | 0.234 |
| C20:0 | 1.43 ± 0.07 | 1.55 ± 0.06 | 1.42 ± 0.08 | 0.616 | 0.560 |
| C18:3N6 | 1.28± 0.07 | 1.55 ± 0.57 | 1.46± 0.12 | 0.012 | 0.528 |
| C20:1 | 1.22 ± 0.14 | 2.85 ± 0.51 | 2.15 ± 0.11 | 0.011 | 0.171 |
| C18:3N3 | 19.28± 0.44 | 13.23 ± 1.22 | 17.02 ± 0.84 | <0.01 | 0.024 |
| C20:2 | 8.33±0.30 | 7.05±0.57 | 8.05±0.34 | 0.078 | 0.149 |
| C20:3N6 | 5.44±0.14 | 6.96±0.64 | 5.68±0.15 | 0.043 | 0.060 |
| C22:1N9 | 2.55±0.11 | 2.04±0.17 | 2.38±0.12 | 0.004 | 0.046 |
| C20:4N6 | 54.83±1.25 | 66.21±5.15 | 59.22±3.44 | 0.057 | 0.271 |
| C24:0 | 7.55±0.22 | 9.82±0.94 | 8.37±0.33 | 0.040 | 0.148 |
| C22:6N3 | 12.38±0.29 | 15.54±1.48 | 14.90±0.59 | 0.063 | 0.681 |
Data are presented as mean ± SEM, n = 6 for each group.
Pt: Control vs. PQ.
Pt: EA vs. PQ.
3.8. Effects of EA supplementation on fatty acid transport- and metabolism-related gene expression in longissimus dorsi muscle
As shown in Figure 6, compared with the control group, PQ challenge significantly decreased the longissimus dorsi muscle mRNA abundance of FABP3, FABP4, CD36, DGAT1, PLIN3, and CPT1B (p < 0.05). In addition, FABP1, CAV1, and PLIN2 showed decreasing trends, whereas FATP4, PNPLA2, and PPARA were not significantly altered (p > 0.05). Compared with the PQ group, EA supplementation significantly increased FABP3, CD36, and PLIN3 mRNA abundance (p < 0.05) and tended to increase CPT1B expression (p = 0.090). No significant differences were observed in FABP1, FABP4, FATP4, CAV1, DGAT1, PLIN2, PNPLA2, or PPARA expression between the PQ and EA groups (p > 0.05). These data show that the transcriptional response to EA was most evident for genes related to fatty acid handling and lipid-droplet regulation.
Figure 6.

Effects of EA supplementation on fatty acid transport and metabolism related gene expression in the longissimus dorsi muscle of PQ-challenged piglets. Relative mRNA expression levels of FABP1, FABP3, FABP4, FATP4, CD36, CAV1, DGAT1, PLIN2, PLIN3, PNPLA2, CPT1B, and PPARα were determined by RT-qPCR. Data are presented as mean ± SEM. n = 6 for each group. *Indicates significant difference (p < 0.05).
4. Discussion
The present study demonstrated that PQ-induced OS markedly disrupted antioxidant capacity and nutrient metabolism in the longissimus dorsi muscle of piglets, whereas dietary EA supplementation partially alleviated these alterations. Although EA supplementation did not significantly improve overall growth performance during the experimental period, clear protective effects were observed at the biochemical and molecular levels, particularly in antioxidant defense, amino acid homeostasis, lipid metabolism, and muscle development. These findings suggest that the protective effects of EA on muscle may occur before substantial improvements in whole-body growth become evident.
OS is characterized by excessive production of reactive oxygen species and an imbalance between oxidant production and antioxidant defense, which can impair cellular macromolecules, mitochondrial function, and tissue metabolism (1, 3). PQ is a potent redox-cycling agent that generates reactive oxygen species and has been widely used to induce oxidative injury (30). Previous studies in piglets have shown that PQ challenge causes intestinal and hepatic oxidative damage, whereas EA supplementation enhances antioxidant capacity and alleviates tissue injury (5–7). Consistent with these observations, the present study showed that PQ challenge impaired antioxidant status in the longissimus dorsi muscle, while EA supplementation partially restored antioxidant-related parameters. EA possesses strong antioxidant properties and can modulate endogenous antioxidant defense systems, including Nrf2-associated signaling (5, 8, 10). Therefore, improvement of muscle redox homeostasis may represent an important mechanism through which EA protects skeletal muscle metabolism during OS.
EA influenced muscle-related gene expression in a marker-specific manner. Oxidative stress can interfere with myogenic differentiation (31, 32), consistent with the PQ-associated reductions in MYOD, MYOG, DESMIN, and CAV3 expression. Among these markers, EA significantly increased CAV3 expression relative to PQ, whereas MYOD, MYOG, and DESMIN were not significantly altered. Given the role of CAV3 in muscle membrane organization, its upregulation suggests a potential contribution to the maintenance of muscle cellular integrity. This selective response distinguishes the effect on CAV3 from the absence of a detectable response in the other three markers.
The increases in FOXO1, P21, and MCP-1 expression following EA supplementation point to additional effects on muscle regulatory processes. FOXO1 is involved in muscle metabolic regulation, although muscle-specific overexpression has also been associated with reduced muscle mass in mice (33). Its increase should therefore be considered a regulatory response whose significance depends on protein activity and downstream targets. P21 coordinates cell-cycle withdrawal during myogenic differentiation (34), suggesting that its elevation may relate to cell-cycle regulation. MCP-1/CCL2 participates in monocyte/macrophage recruitment during muscle repair (35); increased expression may reflect modulation of inflammatory or repair-related signaling. Because FOXO1, P21, and MCP-1 were not significantly changed by PQ versus control, their responses to EA represent additional transcriptional effects rather than demonstrated reversal of PQ-induced alterations. These findings identify candidate processes for mechanistic investigation without equating all three responses with enhanced myogenesis.
The amino acid findings suggest that EA modulates the intramuscular nutrient pool during oxidative challenge. Relative to PQ, EA increased muscle Tau, Glu, Ile, Leu, Phe, and Pro and decreased Thr, Orn, and Lys, whereas serum changes were largely confined to increased Asp. The parallel increases in muscle Tau and SLC6A6 expression are particularly relevant because taurine supports normal muscle function (36, 37). EA also increased SLC1A1 and decreased PRODH, OAT, and ODC expression, indicating coordinated changes in selected transport- and metabolism-related transcripts; SLC25A2 and SLC36A1 were not significantly affected. Increased muscle leucine is biologically relevant given its established role in stimulating protein synthesis (19, 20). Together, these observations suggest that altered amino acid availability and handling may contribute to the metabolic response to EA, while direct measurements of transport and protein turnover would clarify the underlying processes.
EA also affected genes involved in fatty acid handling. The increases in FABP3, CD36, and PLIN3 relative to PQ are consistent with modulation of intracellular fatty acid transport, cellular uptake, and lipid-droplet regulation, respectively (26, 27, 29). These processes connect lipid availability with storage and utilization and may contribute to the muscle metabolic effects of EA. The response was selective: FABP4 and DGAT1 were not significantly altered by EA, and CPT1B showed an upward trend that did not reach significance. Thus, the transcriptional evidence most directly supports effects on fatty acid handling and lipid-droplet regulation.
At the metabolite level, EA increased muscle C18:3 N-3 and C22:1 N-9 relative to PQ, counteracting the decreases associated with PQ challenge. Changes in C16:1, C18:0, and C20:3 N-6 did not reach statistical significance. The significant responses of C18:3 N-3 and C22:1 N-9 complement the increases in FABP3, CD36, and PLIN3 and support an effect of EA on selected aspects of muscle lipid metabolism. This interpretation is consistent with evidence that nutritional and environmental conditions influence porcine muscle fatty acid composition (29, 38).
Several limitations should be acknowledged. Only one EA dose (100 mg/kg diet) was evaluated, leaving its dose dependence and optimal supplementation level unresolved. Muscle morphology and function were not assessed, and the small sample size and short post-challenge period limited evaluation of longer-term outcomes. In addition, metabolite concentrations and mRNA abundance provide indirect evidence of metabolic regulation. Future studies should compare multiple EA doses and incorporate muscle fiber morphology, contractile function, and longer follow-up. Protein-level analyses and measurements of metabolic flux would further clarify how the antioxidant and metabolic responses relate to muscle structure and function.
5. Conclusion
In conclusion, dietary EA supplementation improved antioxidant status in PQ-challenged piglets, as reflected by increased serum T-AOC and GPx activity and muscle SOD activity and GSH content. EA also modulated muscle amino acid profiles, increased C18:3 N-3 and C22:1 N-9, and upregulated SLC1A1, SLC6A6, FABP3, CD36, and PLIN3 relative to PQ. These findings support the potential of EA to alleviate selected biochemical and metabolic disturbances associated with oxidative challenge. Although growth performance was not significantly improved during the experimental period, the antioxidant and metabolic responses provide a basis for further evaluation of EA as a nutritional approach to supporting muscle homeostasis under oxidative stress.
Funding Statement
The author(s) declared that financial support was received for this work and/or its publication. This work was supported by National Natural Science Foundation of China (32573255); Natural Science Foundation of Hunan Province (2024JJ1004).
Footnotes
Edited by: Arda Yıldırım, Gaziosmanpaşa University, Türkiye
Reviewed by: Long Cai, Beijing Academy of Agricultural and Forestry Sciences, China
Loredana Horodincu, Ion Ionescu de la Brad Iasi University of Life Sciences (IULS), Romania
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The animal study was approved by Animal Care and Use Committee of Hunan Agricultural University, Changsha, China. The study was conducted in accordance with the local legislation and institutional requirements.
Author contributions
YD: Data curation, Formal analysis, Funding acquisition, Validation, Writing – original draft. NW: Data curation, Formal analysis, Resources, Visualization, Writing – original draft. YX: Data curation, Formal analysis, Writing – original draft. JW: Funding acquisition, Supervision, Writing – review & editing. XB: Supervision, Writing – review & editing.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that Generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
- 1.Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. (2015) 4:180–3. doi: 10.1016/j.redox.2015.01.002, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in Normal physiological functions and human disease. Int J Biochem Cell Biol. (2006) 39:44–84. doi: 10.1016/j.biocel.2006.07.001, [DOI] [PubMed] [Google Scholar]
- 3.Lykkesfeldt J, Svendsen O. Oxidants and antioxidants in disease: oxidative stress in farm animals. Vet J. (2006) 173:502–11. doi: 10.1016/j.tvjl.2006.06.005, [DOI] [PubMed] [Google Scholar]
- 4.Suntres ZE. Role of antioxidants in paraquat toxicity. Toxicology. (2002) 180:65–77. doi: 10.1016/S0300-483X(02)00382-7, [DOI] [PubMed] [Google Scholar]
- 5.Xiao Y, Huang R, Wang N, Deng Y, Tan B, Yin Y, et al. Ellagic acid alleviates oxidative stress by mediating Nrf2 signaling pathways and protects against paraquat-induced intestinal injury in piglets. Antioxidants (Basel). (2022) 11:252. doi: 10.3390/antiox11020252, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Qi M, Wang N, Xiao Y, Deng Y, Zha A, Tan B, et al. Ellagic acid ameliorates paraquat-induced liver injury associated with improved gut microbial profile. Environ Pollut. (2021) 293:118572. doi: 10.1016/j.envpol.2021.118572 [DOI] [PubMed] [Google Scholar]
- 7.Jin H, Che S, Wu K, Wu M. Ellagic acid prevents gut damage via ameliorating microbe-associated intestinal lymphocyte imbalance. Food Funct. (2022) 13:9822–31. doi: 10.1039/d2fo01512a, [DOI] [PubMed] [Google Scholar]
- 8.Ríos J-L, Giner RM, Marín M, Recio MC. A pharmacological update of ellagic acid. Planta Med. (2018) 84:1068–93. doi: 10.1055/a-0633-9492 [DOI] [PubMed] [Google Scholar]
- 9.Sharifi-Rad J, Quispe C, Castillo CMS, Caroca R, Lazo-Vélez MA, Antonyak H, et al. Ellagic acid: a review on its natural sources, chemical stability, and therapeutic potential. Oxidative Med Cell Longev. (2022) 2022:3848084. doi: 10.1155/2022/3848084, [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 10.Zhang X, Wang S, Wu Y, Liu X, Wang J, Han D. Ellagic acid alleviates diquat-induced jejunum oxidative stress in C57bl/6 mice through activating Nrf2 mediated Signaling pathway. Nutrients. (2022) 14:1103. doi: 10.3390/nu14051103, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.García-Niño WR, Zazueta C. Ellagic acid: pharmacological activities and molecular mechanisms involved in liver protection. Pharmacol Res. (2015) 97:84–103. doi: 10.1016/j.phrs.2015.04.008, [DOI] [PubMed] [Google Scholar]
- 12.Qin W, Xu B, Chen Y, Yang W, Xu Y, Huang J, et al. Dietary ellagic acid supplementation attenuates intestinal damage and oxidative stress by regulating gut microbiota in weanling piglets. Anim Nutr. (2022) 11:322–33. doi: 10.1016/j.aninu.2022.08.004, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lu Y, Zhao M, Mo J, Lan G, Liang J. Dietary supplementation ellagic acid on the growth, intestinal immune response, microbiota, and inflammation in weaned piglets. Front Vet Sci. (2022) 9:980271. doi: 10.3389/fvets.2022.980271, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Qin W, Yu Z, Li Z, Liu H, Li W, Zhao J, et al. Dietary berberine and ellagic acid supplementation improve growth performance and intestinal damage by regulating the structural function of gut microbiota and SCFAs in weaned piglets. Microorganisms. (2023) 11:1254. doi: 10.3390/microorganisms11051254, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Song Z, Deng C, Chen Q, Zhao S, Li P, Wu T, et al. Protective effects and mechanisms of ellagic acid on intestinal injury in piglets infected with porcine epidemic Diarrhea virus. Front Immunol. (2024) 15:1323866. doi: 10.3389/fimmu.2024.1323866, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, et al. Akt/Mtor pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. (2001) 3:1014–9. doi: 10.1038/ncb1101-1014, [DOI] [PubMed] [Google Scholar]
- 17.Glass DJ. Skeletal muscle hypertrophy and atrophy Signaling pathways. Int J Biochem Cell Biol. (2005) 37:1974–84. doi: 10.1016/j.biocel.2005.04.018, [DOI] [PubMed] [Google Scholar]
- 18.Davis TA, Fiorotto ML. Regulation of muscle growth in neonates. Curr Opin Clin Nutr Metab Care. (2009) 12:78–85. doi: 10.1097/MCO.0b013e32831cef9f, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Anthony JC, Yoshizawa F, Anthony TG, Vary TC, Jefferson LS, Kimball SR. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J Nutr. (2000) 130:2413–9. doi: 10.1093/jn/130.10.2413, [DOI] [PubMed] [Google Scholar]
- 20.Suryawan A, Jeyapalan AS, Orellana RA, Wilson FA, Nguyen HV, Davis TA. Leucine stimulates protein synthesis in skeletal muscle of neonatal pigs by enhancing mTORC1 activation. Am J Physiol Endocrinol Metab. (2008) 295:E868–75. doi: 10.1152/ajpendo.90314.2008, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Suryawan A, Nguyen HV, Almonaci RD, Davis TA. Abundance of amino acid transporters involved in Mtorc1 activation in skeletal muscle of neonatal pigs is developmentally regulated. Amino Acids. (2012) 45:523–30. doi: 10.1007/s00726-012-1326-7, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kimball SR, Jefferson LS. Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis. J Nutr. (2006) 136:227S–31S. doi: 10.1093/jn/136.1.227S, [DOI] [PubMed] [Google Scholar]
- 23.Hu CJ, Li FN, Duan YH, Zhang T, Li HW, Yin YL, et al. Dietary supplementation with arginine and glutamic acid alters the expression of amino acid transporters in skeletal muscle of growing pigs. Amino Acids. (2019) 51:1081–92. doi: 10.1007/s00726-019-02748-9, [DOI] [PubMed] [Google Scholar]
- 24.Wang D, Wan X, Peng J, Xiong Q, Niu H, Li H, et al. The effects of reduced dietary protein level on amino acid transporters and Mtor Signaling pathway in pigs. Biochem Biophys Res Commun. (2017) 485:319–27. doi: 10.1016/j.bbrc.2017.02.084, [DOI] [PubMed] [Google Scholar]
- 25.Li YH, Li FN, Wu L, Liu YY, Wei HK, Li TJ, et al. Reduced dietary protein level influences the free amino acid and gene expression profiles of selected amino acid transceptors in skeletal muscle of growing pigs. J Anim Physiol Anim Nutr (Berl). (2016) 101:96–104. doi: 10.1111/jpn.12514, [DOI] [PubMed] [Google Scholar]
- 26.Bonen A, Chabowski A, Luiken JJFP, Glatz JFC. Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology (Bethesda). (2007) 22:15–29. doi: 10.1152/physiologyonline.2007.22.1.15, [DOI] [PubMed] [Google Scholar]
- 27.Zhao SM, Ren LJ, Chen L, Zhang X, Cheng ML, Li WZ, et al. Differential expression of lipid metabolism related genes in porcine muscle tissue leading to different intramuscular fat deposition. Lipids. (2009) 44:1029–37. doi: 10.1007/s11745-009-3356-9, [DOI] [PubMed] [Google Scholar]
- 28.MacPherson REK, Peters SJ. Piecing together the puzzle of perilipin proteins and skeletal muscle lipolysis. Appl Physiol Nutr Metab. (2015) 40:641–51. doi: 10.1139/apnm-2014-0485, [DOI] [PubMed] [Google Scholar]
- 29.Zhong Y, Song B, Zheng C, Li F, Kong X, Duan Y, et al. α-Ketoisocaproate and β-hydroxy-β-methyl butyrate regulate fatty acid composition and lipid metabolism in skeletal muscle of growing pigs. J Anim Physiol Anim Nutr (Berl). (2019) 103:846–57. doi: 10.1111/jpn.13077, [DOI] [PubMed] [Google Scholar]
- 30.Dinis-Oliveira RJ, Duarte JA, Sánchez-Navarro A, Remião F, Bastos ML, Carvalho F. Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit Rev Toxicol. (2008) 38:13–71. doi: 10.1080/10408440701669959, [DOI] [PubMed] [Google Scholar]
- 31.Ardite E, Barbera JA, Roca J, Fernández-Checa JC. Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2c12 cells through sustained Nf-Kappab activation. Am J Pathol. (2004) 165:719–28. doi: 10.1016/S0002-9440(10)63335-4, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Fulle S, Protasi F, Di Tano G, Pietrangelo T, Beltramin A, Boncompagni S, et al. The contribution of reactive oxygen species to sarcopenia and muscle ageing. Exp Gerontol. (2004) 39:17–24. doi: 10.1016/j.exger.2003.09.012, [DOI] [PubMed] [Google Scholar]
- 33.Kamei Y, Miura S, Suzuki M, Kai Y, Mizukami J, Taniguchi T, et al. Skeletal muscle Foxo1 (Fkhr) transgenic mice have less skeletal muscle mass, down-regulated type I (slow twitch/red muscle) Fiber genes, and impaired Glycemic control. J Biol Chem. (2004) 279:41114–23. doi: 10.1074/jbc.M400674200, [DOI] [PubMed] [Google Scholar]
- 34.Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of P21 by Myod. Science. (1995) 267:1018–21. doi: 10.1126/science.7863327, [DOI] [PubMed] [Google Scholar]
- 35.Martinez CO, McHale MJ, Wells JT, Ochoa O, Michalek JE, McManus LM, et al. Regulation of skeletal muscle regeneration by CCR2-activating chemokines is directly related to macrophage recruitment. Am J Physiol Regul Integr Comp Physiol. (2010) 299:R832–42. doi: 10.1152/ajpregu.00797.2009, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Warskulat U, Flögel U, Jacoby C, Hartwig H-G, Thewissen M, Merx MW, et al. Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. FASEB J. (2004) 18:577–9. doi: 10.1096/fj.03-0496fje, [DOI] [PubMed] [Google Scholar]
- 37.Ito T, Oishi S, Takai M, Kimura Y, Uozumi Y, Fujio Y, et al. Cardiac and skeletal muscle abnormality in taurine transporter-knockout mice. J Biomed Sci. (2010) 17 Suppl 1:S20. doi: 10.1186/1423-0127-17-S1-S20, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Xu Z, Chen W, Wang L, Zhou Y, Nong Q, Valencak TG, et al. Cold exposure affects lipid metabolism, fatty acids composition and transcription in pig skeletal muscle. Front Physiol. (2021) 12:748801. doi: 10.3389/fphys.2021.748801, [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
